Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy-Reference-Cited by-同舟云学术

Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy

Published:2022-04 Issue:4 Volume:135 Page:350-356
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Tseng Laura A.,Abdenur Jose E.,Andrews Ashley,Aziz Verena G.,Bok Levinus A.,Boyer Monica,Buhas Daniela,Hartmann Hans,Footitt Emma J.,Grønborg Sabine,Janssen Mirian C.H.,Longo Nicola,Lunsing Roelineke J.,MacKenzie Alex E.,Wijburg Frits A.,Gospe Sidney M.,Coughlin Curtis R.,van Karnebeek Clara D.M.

Funder

National Center for Advancing Translational Sciences

Stichting Metakids

National Institutes of Health

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy;Coughlin;J. Inherit. Metab. Dis.,2019

2. Epidemiology of pyridoxine dependent seizures in the Netherlands;Been;Arch. Dis. Child.,2005

3. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine;Hunt;Pediatrics,1954